Morgan Stanley
UTRS

Morgan Stanley’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Morgan Stanley’s Portfolio UTRS Stock Details UTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-462
Closed -$2.37K – 7742
2023
Q2 		$2.37K Hold
462
– – ﹤0.01% 7159
2023
Q1 		$2.03K Sell
462
-839
-64% -$5.16K ﹤0.01% 7233
2022
Q4 		$5.81K Buy
+1,301
New +$8.64K ﹤0.01% 7112
2022
Q2 		– Sell
-500
Closed -$45K – 8100
2022
Q1 		$45K Buy
+500
New +$50.8K ﹤0.01% 6762
2021
Q4 		– Hold
0
– – – 8204

Other funds holding UTRS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FRA
Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley's UTRS Position: Q3 2023 in Review

Morgan Stanley sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q3 2023, closing a stake of 462 shares — an estimated $2.37K sold.

Morgan Stanley first reported a position in UTRS in Q1 2022 and held it in 4 quarters. The position peaked at $45K in Q1 2022. 13 funds tracked by Wall St. Rank hold UTRS as of Q3 2023.

  • Morgan Stanley reported no remaining Minerva Surgical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 462 Minerva Surgical, Inc. Common Stock shares in Q3 2023, an estimated $2.37K.
  • Morgan Stanley first reported a position in Minerva Surgical, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Morgan Stanley's Minerva Surgical, Inc. Common Stock position peaked at $45K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.